You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent glioblastoma multiforme (GBM)

Showing 1 - 25 of 8,697
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme Trial in Australia, United States (Nativis Voyager RFE Therapy)

Completed
  • Glioblastoma Multiforme
  • Nativis Voyager RFE Therapy
  • Birmingham, Alabama
  • +12 more
Jan 31, 2023

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Brain and Nervous System Trial in Palo Alto (B7-H3CART)

Recruiting
  • Brain and Nervous System
  • Palo Alto, California
    Stanford Cancer Institute
Jul 22, 2022

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022

GBM, Glioblastoma Multiforme, Gliosarcoma Trial in Providence, Dallas (PSMA ADC)

Completed
Has Results
  • GBM
  • +2 more
  • PSMA ADC
  • Providence, Rhode Island
  • +1 more
Nov 22, 2021

Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)

Available
  • Recurrent Glioblastoma
  • TVI-Brain 1
  • Portland, Oregon
    Providence St. Vincent Medical Center
Jun 28, 2023

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Recurrent Glioblastoma Multiforme(GBM) Trial in Houston (ACT001, ACT001 + Pembrolizumab)

Recruiting
  • Recurrent Glioblastoma Multiforme(GBM)
  • Houston, Texas
    UT MD Anderson Cancer Center, Dept of Neuro-Oncology
Nov 12, 2021

Glioblastoma Multiforme Trial in Australia, Austria, Netherlands (4-L-[131I]iodo-phenylalanine (131I-IPA))

Active, not recruiting
  • Glioblastoma Multiforme
  • 4-L-[131I]iodo-phenylalanine (131I-IPA)
  • Gateshead, New South Wales, Australia
  • +4 more
Nov 25, 2021

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma

Recruiting
  • Recurrent Glioblastoma Multiforme (GBM)
  • +3 more
  • Los Angeles, California
  • +4 more
May 5, 2022

Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)

Recruiting
  • Recurrent GBM
  • SONALA-001 (ALA) and Exablate device
  • Phoenix, Arizona
  • +2 more
Jan 6, 2023

Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

Active, not recruiting
  • Glioblastoma Multiforme
  • VBI-1901
  • +2 more
  • Los Angeles, California
  • +3 more
Jun 27, 2022

Solid Tumors (Phase 1), Relapsed/Recurrent GBM (Phase 2) Trial in Spain, United States (USL311, Lomustine)

Terminated
Has Results
  • Solid Tumors (Phase 1)
  • Relapsed/Recurrent GBM (Phase 2)
  • Saint Louis, Missouri
  • +5 more
Jul 1, 2021

Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

Active, not recruiting
  • Glioblastoma Multiforme of Brain
  • +2 more
  • C134
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 19, 2022

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Glioblastoma Multiforme Trial (Birabresib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • (no location specified)
Jan 7, 2021